Literature DB >> 830409

Inhibition of DNA methylation by S-adenosylethionine with the production of methyl-deficient DNA in regenerating rat liver.

R Cox, C C Irving.   

Abstract

Ethionine, a liver carcinogen, was administered p.o. (300 mg/kg) to rats 17 hr after partial hepatectomy. At 6 hr after administration of the ethionine, hepatic S-adenosylethionine levels were 30- to 40-fold greater than the hepatic level of S-adenosylmethionine. A 10-fold ratio of S-adenosylethionine to S-adenosylmethionine still persited at 24 hr after ethionine administration. When given at 17 hr after partial hepatectomy, ethionine produced a 30% inhibition of DNA synthesis, measured by the incorporation of [methyl-3H]thymidine at 23 to 24 hr after partial hepatectomy (6 to 7 hr after ethionine administration). DNA synthesized during this interval was methyl deficient as judged by the reduced incorporation of radioactivity from L-[methyl-3H]methionine into 5-methylcytosine residues of DNA. In an assay for DNA methylation in vitro using whole nuclei, the methyl-deficient DNA was methylated by S-adenosylmethionine 8 times more than was control DNA; the DNA methylation was competitively inhibited by S-adenosylethionine. These data suggest that S-adenosylethionine, formed in vivo from ethionine, competitively inhibits the methylation of DNA in vivo by S-adenosylmethionine, resulting in the production of methyl-deficient DNA.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 830409

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Functionally impaired tRNA from ethionine treated rats as detected in injected Xenopus oocytes.

Authors:  I Ginzburg; P Cornelis; D Giveon; U Z Littauer
Journal:  Nucleic Acids Res       Date:  1979-02       Impact factor: 16.971

2.  DNA methylation of embryogenic carrot cell cultures and its variations as caused by mutation, differentiation, hormones and hypomethylating drugs.

Authors:  F Loschiavo; L Pitto; G Giuliano; G Torti; V Nuti-Ronchi; D Marazziti; R Vergara; S Orselli; M Terzi
Journal:  Theor Appl Genet       Date:  1989-03       Impact factor: 5.699

3.  Reduced protein kinase C activity and endogenous protein phosphorylation in ethionine-induced fatty liver in cows.

Authors:  N Katoh
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

4.  Characterization of rat liver cells transformed in culture by DL-ethionine.

Authors:  U I Heine; M J Wilson; E F Munoz
Journal:  In Vitro       Date:  1984-04

Review 5.  Molecular aspects of the in vivo and in vitro effects of ethionine, an analog of methionine.

Authors:  J H Alix
Journal:  Microbiol Rev       Date:  1982-09

6.  Chemical carcinogen-induced decreases in genomic 5-methyldeoxycytidine content of normal human bronchial epithelial cells.

Authors:  V L Wilson; R A Smith; J Longoria; M A Liotta; C M Harper; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  Enhancement of biotinidase activity in mouse serum by inhibitors of methylation.

Authors:  V P Kontinen; J P Pispa
Journal:  Mol Cell Biochem       Date:  1987-07       Impact factor: 3.396

8.  Detection of numerical chromosome aberrations in bladder cancer by in situ hybridization.

Authors:  A H Hopman; P J Poddighe; A W Smeets; O Moesker; J L Beck; G P Vooijs; F C Ramaekers
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

9.  S-Adenosyl-l-ethionine is a Catalytically Competent Analog of S-Adenosyl-l-methione (SAM) in the Radical SAM Enzyme HydG.

Authors:  Stella Impano; Hao Yang; Eric M Shepard; Ryan Swimley; Adrien Pagnier; William E Broderick; Brian M Hoffman; Joan B Broderick
Journal:  Angew Chem Int Ed Engl       Date:  2020-12-01       Impact factor: 15.336

10.  Growth of methionine-dependent human prostate cancer (PC-3) is inhibited by ethionine combined with methionine starvation.

Authors:  F Poirson-Bichat; G Gonfalone; R A Bras-Gonçalves; B Dutrillaux; M F Poupon
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.